Joel LeMaoult

3PUBLICATIONS
23CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

Sort by Publication Date:
|Jun 08, 2026
ILT2 Identifies an Unexploited Pool of Intratumoral CD8+ Bystander T Cells with TCR-Independent Cytotoxicity in Renal Cell Carcinoma.

|Jul 02, 2021
Human Keratinocytes Inhibit CD4+ T-Cell Proliferation through TGFB1 Secretion and Surface Expression of HLA-G1 and PD-L1 Immune Checkpoints.

Guillaume Mestrallet, Frédéric Auvré, Chantal Schenowitz

|Aug 28, 2019
CD8+PD-1-ILT2+ T Cells Are an Intratumoral Cytotoxic Population Selectively Inhibited by the Immune-Checkpoint HLA-G.

Clement Dumont, Alix Jacquier, Jerome Verine

Pageof 1

Frequent Collaborators

1 joint publications

Floriane Noel

1 joint publications

Ching-Lien Wu

1 joint publications

Tzu-Min Hung

1 joint publications

Guillaume Mestrallet

1 joint publications

Michèle T Martin

1 joint publications

Nicolas O Fortunel

1 joint publications

Rebecca Laboureur

1 joint publications

Clément Dumont

1 joint publications

Dzenis Koca

1 joint publications

Leonard Lugand

Frequent Collaborators

1 joint publications

Floriane Noel

1 joint publications

Ching-Lien Wu

1 joint publications

Tzu-Min Hung

1 joint publications

Guillaume Mestrallet

JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us